Influenza
319 results
1 - 100
Characteristics of patients with H1N1 influenza- Influenza vaccination during pregnancy is effective
- Enhanced influenza vaccines prevent more hospitalizations than standard-dose influenza vaccines in older adults
- Baloxavir is effective for influenza prophylaxis in household contacts
- Influenza (H1N1) vaccination during pregnancy not associated with autism
- Egg-allergic children can receive influenza vaccine
- Adjuvant increases efficacy of influenza vaccine in infants and children
- Antivirals can prevent influenza but treatment of symptoms is less impressive
- Acute cardiovascular events are common in patients hospitalized with influenza
- Surgical mask and N95 respirator similarly effective for preventing influenza
- FluScoreVax incorporates vaccination history to accurately predict influenza risk
- Rapid influenza tests reduce ER testing in kids, little else
- Live attenuated influenza vaccine not effective in recent US flu seasons
- Study confirms benefits of early administration of oseltamivir for hospitalized patients with influenza
- Influenza vaccine during pregnancy not associated with adverse childhood health outcomes
- Validated clinical decision rule to guide management for patients with suspected influenza
- Further evidence no difference between N95 respirator and medical mask for influenza prevention
- H1N1 influenza vaccination during pregnancy not associated with problems in exposed offspring
- In adults with medical comorbidities, influenza vaccinations are associated with a lower risk of developing dementia
- Anti-influenza drugs have no effect on mortality or hospitalization and reduce symptoms by 24 hours or less
- Quadrivalent recombinant influenza vaccine seems safe and effective for adults older than 50 years
- Avian influenza A(H5N1) generally causes mild illness in humans with no human-to-human spread in 46 cases
- Same-day COVID-19 and seasonal influenza vaccines are as effective as each vaccine given separately
- For adults presenting to the emergency department, mortality is 7.9% for COVID-19 (Omicron), 6.0% for RSV, and 2.5% for influenza
- Low-certainty evidence suggests oseltamivir and peramivir may reduce hospital length of stay in adults with severe influenza
- Influenza vaccine shortly after myocardial infarction reduces 1-year mortality (NNT = 50)
- High-dose influenza vaccine no more effective than the standard dose for adults with high-risk cardiovascular disease
- Postexposure prophylaxis with direct antivirals is more effective than placebo or usual care in preventing symptomatic seasonal and zoonotic influenza
- mRNA flu vaccine somewhat more effective at preventing influenza than standard vaccine in adults 18 to 64 years (NNI = 300)